Sep 20 |
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
|
Sep 19 |
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
|
Sep 19 |
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
|
Sep 17 |
Ascendis Soars on Encouraging Data From Dwarfism Drug Study
|
Sep 17 |
Illumina, Inc. (NASDAQ:ILMN): A Non-Tech Stock With Long-Term Investment Potential
|
Sep 13 |
Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually
|
Sep 10 |
Illumina and Exxon Mobile have been highlighted as Zacks Bull and Bear of the Day
|
Sep 10 |
Bull of the Day: Illumina (ILMN)
|
Sep 4 |
Illumina files for potential mixed shelf
|
Sep 3 |
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal
|